Superantigen bacterial toxins: State of the art

Toxicon

Volumn 39, Issue 11, 2001, Pages 1691-1701

  Müller Alouf, Heide ^a   Carnoy, Christophe ^b,c,e   Simonet, Michel ^b   Alouf, Joseph E ^d  

^a INSTITUT PASTEUR DE LILLE   (France)

^b INSERM   (France)

^c UNIV LILLE   (France)

^d INSTITUT PASTEUR   (France)

^e INSTITUT DE BIOLOGIE DE LILLE   (France)

Author keywords

Cytokine; Enterotoxin; Major histocompatibility complex; Mitogen; Mycoplasma arthritidis; Staphylococcus; Streptococcus; Superantigen; T cell receptor; Toxic shock syndromes; V repertoire; Yersinia pseudotuberculosis

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; ENTEROTOXIN; ERYTHROGENIC TOXIN A; ERYTHROGENIC TOXIN C; EXFOLIATIN; MITOGENIC AGENT; PROTEIN MAM; PROTEIN SMEZ 2; PROTEIN SPEG; PROTEIN SPEH; PROTEIN SPEJ; PROTEIN YPM; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN PRESENTING CELL; BETA CHAIN; CELL SURFACE; CLOSTRIDIUM PERFRINGENS; CYTOKINE RELEASE; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MYCOPLASMA ARTHRITIDIS; NONHUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTEIN MOTIF; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS PYOGENES; T LYMPHOCYTE; YERSINIA PSEUDOTUBERCULOSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); MYCOPLASMA ARTHRITIDIS; STAPHYLOCOCCUS; STREPTOCOCCUS; YERSINIA PSEUDOTUBERCULOSIS;

EID: 0034861858     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(01)00156-8     Document Type: Short Survey

References (110)

1. Clinical role for a superantigen in Yersinia pseudotuberculosis infection
2. Stuctural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1
3. Superantigenic Streptococcus pyogenes erythrogenic pyrogenic exotoxins
4. Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes
5. Streptococcal toxic shock syndrome associated with marked γδ T cell expansion: Case report
6. Cases of Yersinia pseudotuberculosis infection having diagnostic criteria of Kawasaki disease
7. Staphylococcus aureus
8. Functional analysis of Mycoplasma arthritidis-derived mitogen interactions with class II molecules
9. Clostridium perfringens enterotoxin is a superantigen reactive with human T cell receptors Vβ 6.9 an Vβ 22
10. The reemergence of serious group A streptococcal infections and acute rheumatic fever
11. Yersinia pseutoduberculosis superantigenic toxins
12. Superantigen YPMa exacerbates the virulence of Yersinia pseutoduberculosis in mice
13. The structure of Staphylococcus aureus epidermolytic toxin A, an atypic serine protease, at 1.7 Å resolution
14. An alternative method for T-cell repertoire analysis: Clustering of human V-beta subfamilies selected in response to straphylococcal enterotoxins B and E
15. Streptococcal pyrogenic exotoxins A (SpeA) and C (SpeC) stimulate the production of inducible nitric oxide synthase (iNOS) protein in RAW 264.7 macrophages
16. The Mycoplasma arthritidis T-cell mitogen, MAM: A model superantigen
17. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis I. Transformation is associated with an H-2-linked gene that maps to the I-E/I-C subregion
18. The use of transfected fibroblasts and transgenic mice establishes that stimulation of T cells by the Mycoplasma arthritidis mitogen is mediated by Eα
19. The sequence of the Mycoplasma arthritidis superantigen, MAM: Identification of functional domains and comparison with microbial superantigens and plant lectin mitogens
20. Allelic polymorphisms at the H-2A and HLA-DQ loci influence the response of murine lymphocytes to the Mycoplasma arthritidis superantigen MAM
21. Mycoplasma-induced arthritis in animals: Relevance to understanding the etiologies of the human rheumatic diseases
22. Human B cell differentiation induced by microbial superantigens: Unselected peripheral blood lymphocytes secrete polyclonal immunoglobulin in response to Mycoplasma arthritidis mitogen
23. Colonic epithelial physiology is altered in response to the bacterial superantigen Yersinia pseudotuberculosis mitogen
24. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production
25. Superantigens produced by infectious pathogens: Molecular mechanism of action and biological significance
26. Superantigens: A tool to gain new insight into cellular immunity
27. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor β synthesis
28. Staphylococcus aureus toxic shock syndrome toxin 1 and Streptococcus pyogenes erythrogenic toxin A modulate inflammatory mediator release from human neutrophils
29. Mycoplasma superantigen is a CDR3-dependent ligand for the T cell antigen receptor
30. Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1
31. Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein
32. Analysis of functional regions of YPM, a superantigen derived from Gram-negative bacteria
33. Cloning, characterization and overexpression of a Streptococcus pyogenes gene encoding a new type of mitogenic factor
34. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen
35. Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon
36. Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes
37. Molecular population genetic evidence of horizontal spread of two alleles of the pyrogenic exotoxin C gene (speC) among pathogenic clones of Streptococcus pyogenes
38. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1
39. Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A
40. Superantigens in human diseases
41. Clostridium perfringens enterotoxin lacks superantigenic activity but induces an interleukin-6 response from human peripheral blood mononuclear cells
42. Streptococcal toxic shock syndrome
43. Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, erythrogenic toxin A): Generation of interleukin-8
44. Clinical, microbial and biochemical aspects of the exfoliative toxins causing straphylococcal scalded-skin syndrome
45. Superantigens in Kawasaki syndrome
46. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis
47. Three dimensional structure of the complex between a T-cell receptor beta chain and the superantigen staphylococcal enterotoxin B
48. The toxic shock syndrome toxin-1 induces anergy in human T cells in vivo
49. The staphylococcal enterotoxins and their relatives
50. Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression
51. Streptococcal toxic shock-like syndrome: Evidence of superantigen activity and its effects on T lymphocyte subsets in vivo
52. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: Critical role of tumor necrosis factor
53. Mechanisms of peripheral T cell deletion: Anergized T cells are Fas resistant but undergo proliferation associated apoptosis
54. DNA sequencing of the gene encoding a bacterial superantigen. Yersinia pseudotuberculosis-derived mitogen (YPM), and characterization of the gene product, cloned YPM
55. Identification of murine T cells reactive with the bacterial superantigen Yersinia pseudotuberculosis-derived mitogen (YPM) and factors involved in YPM-induced toxicity in mice
56. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C
57. Properties of Staphylococcus aureus enterotoxins and toxic shock syndrome toxin-1
58. Unique superantigen activity of staphylococcal exfoliative toxins
59. Identification and characterization of staphylococcal enterotoxin types G and I from Staphylococcus aureus
60. Streptococcal superantigen, mitogenic factor and pyrogenic exotoxin B expressed by Streptococcus pyogenes. Structure and function
61. Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci and lipopolysaccharide
62. Human pro- and anti-inflammatory cytokine patterns induced by Streptococcus pyogenes erythrogenic (pyrogenic) exotoxins A and C superantigens
63. Streptococcal pyrogenic exotoxin A (SPEA) superantigen induced production of hematopoietic cytokines, IL-12 and IL-13 by human peripheral blood mononuclear cells
64. T cell activation and cytokine release in streptococcal toxic shock-like syndrome
65. Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes
66. Isolation of a new superantigen with potent mitogenic activity to murine T cells from Streptococcus pyogenes
67. Streptococcal superantigens and their role in the pathogenesis of severe infections
68. Superantigenic properties of the group A streptococcal exotoxin SPEF (MF)
69. Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site
70. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1-5 Å resolution: Implications for superantigen recognition by MHC class II molecules and T cell receptors
71. Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T cell receptors
72. Staphylococcal epidermolytic toxins: Structure, biological and pathophysiological properties
73. Structure of toxic shock syndrome toxin 1
74. Identification and characterization of novel superantigens from Streptococcus pyogenes
75. The streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure and significant antigenic variation
76. Purification, characterization and cloning of a novel variant of the superantigen Yersinia pseudotuberculosis-derived mitogen
77. Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes
78. Erythrogenic toxins A, B and C: Occurrence of the genes and exotoxin formation from clinical Streptococcus pyogenes strains associated with streptococcal toxic shock-like syndrome
79. Characterization and biological properties of a new staphylococcal exotoxin
80. Superantigenicity of helper T-cell mitogen (SPM-2) isolated from culture supernatants of Streptococcus pyogenes
81. Induction of a cytokine network by superantigens with parallel TH1 and TH2 stimulation
82. Crystal structure of the streptococcal superantigen superantigen SPE-C: Dimerization and zinc binding suggest a novel mode of interaction with MHC class II molecules
83. The neighbor-joining method: A new method for reconstructing phylogenetic trees
84. Yersinia pseutoduberculosis infection in children, resembling Izumi fever and Kawasaki syndrome
85. Anti-MAM antibodies in rheumatic disease: Evidence for a MAM-like superantigen in rheumatoid arthritis?
86. Crystal structure of the superantigen staphylococcal enterotoxin type A
87. Superantigens and their role in infectious disease
88. Generated single point-mutations can considerably dismantle the lymphocyte overstimulation induced by Yersinia pseudotuberculosis superantigen
89. Bacterial superantigen-induced human lymphocyte responses are nitric oxide dependent and mediated by IL-12 and IFN-γ
90. Streptococcal toxic shock syndrome: Spectrum of disease, pathogenesis and new concepts in treatment
91. Severe group A streptococcal infections associated with toxic shock-like syndrome and scarlet fever toxin A
92. CD95 (Fas)-based, superantigen-dependent, CD4 + T cell-mediated down-regulation of human in vitro immunoglobulin responses
93. Yersinia enterocolitica produces superantigenic activity
94. Characterization of human T-cell responses to Yersinia enterocolitica superantigen
95. Structural basis for HLA-DQ binding by the streptococcal superantigen SSA
96. 2+ at 2.7 Å resolution. Implications for major histocompatibility complex class II binding
97. 2+-mediated homodimerization
98. Staphylococcal enterotoxins A, D and E. Structure and function, including mechanism of T-cell superantigenicity
99. Crystal structure of staphylococcal enterotoxin B, a superantigen
100. Definition of the mitogenic factor (MF) as a novel streptococcal superantigen that is different from streptococcal pyrogenic exotoxins A, B and C
101. Helper T cell-dependent human B cell differentiation mediated by a mycoplasmal superantigen bridge
102. Bacterial superantigens: Mechanism of T cell activation by the superantigens and their role in the pathogenesis of infections diseases
103. Bacterial superantigens in human disease: Structure, function and diversity
104. The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease
105. The Vβ-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice
106. Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome
107. Geographical heterogeneity between Far East and Europe in prevalence of ypm gene encoding the novel superantigen among Yersinia pseucotuberculosis strains
108. Identification of the functional region on the superantigen Yersinia pseudotuberculosis-derived mitogen responsible for induction of lymphocyte proliferation by using synthetic peptides
109. The superantigen exfoliative toxin induces cutaneous lymphocyte-associated antigen expression in peripheral human T lymphocytes